Gene / Region Examined
KRAS Exon 1, KRAS Exon 2, KRAS Exon 3, KRAS Exon 4, KRAS Exon 5, KRAS Exon 6
Goal and Purpose
Colorectal Cancer, Non-Small Cell Lung Cancer (NSCLC), Gastric Cancer,Familial Breast Cancer,Acute Myelogenous Leukemia (AML),Pancreatic Carcinoma, Transitional cell, Urinary Bladder Carcinoma. Response to drug treatment: Erbitux (Cetuximab), Vectibix (Panitumumab), Tarceva (Erlotinib), Iressa (Gefitinib), Avastin (Bevacizumab)